Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kestra Medical TechnologiesKMTS +4.90%12 PS Ratio is 13.72 as of Aug. 04, 2026, which is 2% above its 10-year median of 13.48. GuruFocus rates KMTS with a GF Score™ of 12/100. The stock has 5 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Kestra Medical Technologies ranks worse than 88.43% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Kestra Medical Technologies's share price is $23.99.
Kestra Medical Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 was $1.75. Hence, Kestra Medical Technologies's PS Ratio for today is 13.72.
The historical rank and industry rank for Kestra Medical Technologies's PS Ratio or its related term are showing as below:
KMTS'
s PS Ratio Range Over the Past 10 Years
Min: 8.25 Med: 13.48 Max: 18.78
Current: 13.72
During the past 6 years, Kestra Medical Technologies's highest PS Ratio was 18.78. The lowest was 8.25. And the median was 13.48.
KMTS's PS Ratio is ranked worse than 88.43% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.935
vs KMTS: 13.72
During the past 6 years, Kestra Medical Technologies's highest 3-Year average Revenue per Share Growth Rate was 66.00% per year. The lowest was 66.00% per year. And the median was 66.00% per year.
Kestra Medical Technologies (NAS:KMTS) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Kestra Medical Technologies PS Ratio Related Terms
Kestra Medical Technologies PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Kestra Medical Technologies's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kestra Medical Technologies PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Kestra Medical Technologies's PS Ratio distribution charts can be found below:
* The bar in red indicates where Kestra Medical Technologies's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Kestra Medical Technologies's Share Price of today is $23.99. Kestra Medical Technologies's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.75.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Kestra Medical Technologies (KMTS) has a PS Ratio of 13.72 as of Aug. 04, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kestra Medical Technologies and its competitors. This is near median its historical median of 13.48. Over the past decade, Kestra Medical Technologies' PS Ratio has ranged from 8.25 to 18.78. According to the industry distribution chart, Kestra Medical Technologies ranks #711 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 88.4%.
Is Kestra Medical Technologies' PS Ratio too high?
Kestra Medical Technologies' current PS Ratio of 13.72 is near median its 10-year median of 13.48. Over the past 10 years, this metric has ranged from a low of 8.25 to a high of 18.78. The Medical Devices & Instruments industry median PS Ratio is 2.94. Kestra Medical Technologies' value of 13.72 is 367.5% above this industry median. Based on the distribution chart, Kestra Medical Technologies ranks #711 out of 804 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Kestra Medical Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Kestra Medical Technologies' PS Ratio compare to AZTA and STAA?
According to the Medical Devices & Instruments industry distribution chart, Kestra Medical Technologies ranks #711 out of 804 companies for PS Ratio. This places Kestra Medical Technologies in the lower half of its industry. The industry median PS Ratio is 2.94. Kestra Medical Technologies' value of 13.72 is 367.5% above this benchmark. Historically, Kestra Medical Technologies' own PS Ratio has ranged from 8.25 to 18.78 over the past decade. While the company's 10-year median is 13.48 vs. the industry median of 2.94, Kestra Medical Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kestra Medical Technologies's current PS Ratio of 13.72 is 367.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Kestra Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kestra Medical Technologies's current PS Ratio is 13.72, which is near median its own 10-year median of 13.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kestra Medical Technologies stock overvalued right now?
Kestra Medical Technologies (KMTS) has a current PS Ratio of 13.72. The current PS Ratio is 13.72, which is near median its 10-year median of 13.48 and 367.5% above the Medical Devices & Instruments industry median of 2.94. Kestra Medical Technologies' overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Kestra Medical Technologies (KMTS), the current PS Ratio is 13.72 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kestra Medical Technologies Ltd is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. It has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and developed system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of its Cardiac Recovery System platform is the ASSURE WCD, a next-generation wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA), a prominent public health problem.
12GF Score
Get the complete analysis for KMTS
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KMTS has been successfully added to your 
